Released on: September 30, 2008, 5:42 am

Press Release Author: The Scott Partnership

Industry: -- Choose an Industry --

Press Release Summary:
(30 September, 2008) Exco InTouch, the leading mobile messaging provider for the
pharmaceutical industry, announces that its electronic patient reported outcomes
(ePRO) solutions have been selected by Synairgen, a drug discovery company focused
on asthma and chronic obstructive pulmonary disease (COPD).
Exco InTouch's short message service (SMS) ePRO offerings will enable Synairgen to
collect patient data in its second clinical study of inhaled interferon beta
(IFN-beta) for asthma treatment.


Press Release Body: Exco InTouch's Electronic Patient Diary Selected by Synairgen to
Capture ePRO Data in IFN-beta Asthma Trial

(30 September, 2008) Exco InTouch, the leading mobile messaging provider for the
pharmaceutical industry, announces that its electronic patient reported outcomes
(ePRO) solutions have been selected by Synairgen, a drug discovery company focused
on asthma and chronic obstructive pulmonary disease (COPD).
Exco InTouch's short message service (SMS) ePRO offerings will enable Synairgen to
collect patient data in its second clinical study of inhaled interferon beta
(IFN-beta) for asthma treatment.

This Phase 1 study from Synairgen is designed to establish the safety of inhaled
IFN-beta at four different dose levels over a 14 day period in asthmatic volunteers.
Exco InTouch's innovative text messaging ePRO system will enable Synairgen to
collect accurate PRO data which might be crucial in gauging the efficacy in future
studies.

Using secure mobile online access, this technology will allow patients to complete
diary questionnaires at pre-specified times via a series of text messages. Secure
text messages will enable Synairgen's patients to easily record and transmit data
concerning their asthma using their own mobile phone, facilitating diary data
collection which is then relayed back to the clinical sites for further analyses.

"Symptom diary cards are notoriously unreliable; we are attracted to this simple
method for collecting asthma symptom scores on a daily basis" said Richard Marsden,
Managing Director of Synairgen

About Exco InTouch's ePRO Solutions
For more complex data collection, a java application which runs on the patient's own
mobile phone can be used in mobile data capture, dose titration and disease
exacerbation monitoring. Simple and easy to deploy, Exco InTouch's software can be
used for daily questionnaires in conjunction with the REACT compliance platform to
deliver high quality data within appropriate timeframes.

For further information on the Exco InTouch ePRO portfolio, please call +44
1279 408 210 or +1 949 725 2946 or visit www.excointouch.com
-ENDS-

For further press information please contact: Eleanor CallanMonk, The Scott
Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA Tel:
+44 1477 539539 Fax: +44 1477 539540 e-mail: exco@scottpr.com


Web Site: http://

Contact Details: For further press information please contact: Eleanor CallanMonk,
The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA
Tel:
+44 1477 539539 Fax: +44 1477 539540 e-mail: exco@scottpr.com